Osteoarthritis - Drug Pipeline Analysis And Market Forecasts To 2016

GlobalData, the industry analysis specialist's new2.4 Drivers and Barriers for the Osteoarthritis
report, "Osteoarthritis – Drug Pipeline Analysis andTherapeutics Market 7
Market Forecasts to 2016" is an essential source of2.4.1 Drivers for the Osteoarthritis Therapeutics
information and analysis on the global osteoarthritisMarket 7
market. The report identifies the key trends shaping2.4.2 Barriers for the Osteoarthritis Therapeutics
and driving the global osteoarthritis market. TheMarket 8
report also provides insight on the prevalent2.5 Opportunity and Unmet Need 8
competitive landscape and the emerging players2.6 Key Takeaway 9
expected to bring significant shift in the market3 Osteoarthirtis Market: Competitive Assessment 10
positioning of the existing market leaders. Most3.1 Overview 10
importantly, the report provides valuable insight on3.2 Strategic Competitor Assessment 10
the pipeline products within the global osteoarthritis3.3 Product Profiles of the Major Marketed Products
sector.in the Osteoarthritis Therapeutics Market 11
This report is built using data and information sourced3.3.1 Voltaren Gel 11
from proprietary databases, primary and secondary3.3.2 Celebrex 11
research and in house analysis by GlobalData's team3.3.3 Hyalgan 12
of industry experts.3.3.4 Mobic 12
Scope3.4 Key Takeaway 13
The report analyzes market opportunities and4 Osteoarthritis Market: Pipeline Assessment 14
challenges for the global osteoarthritis market. Its4.1 Overview 14
scope includes4.2 Strategic Pipeline Assessment 14
- Annualized global osteoarthritis market revenues4.2.1 Technology Trends Analytic Framework 14
data from 2001 to 2009, forecast forward for 74.3 Osteoarthritis Therapeutics – Promising Drugs
years to 2016.under Clinical Development 15
- Geographies covered in this report include the US,4.4 Molecule Profile for Promising Drugs under Clinical
the UK, Italy, Spain, Germany, France and Japan.  Development 16
- Pipeline analysis data providing a split across4.4.1 SD6010 16
different phases by mechanism of action being4.4.2 PF-4383119 16
developed and emerging trends. Key classes of4.4.3 TDS-943 16
mechanism of action include serotonin-norepinephrine4.4.4 SMC021 17
reuptake inhibitors, calcium homeostasis regulators,4.4.5 CG5503 17
and proton pump inhibitors, inhibitor of 5-lipoxygenase4.4.6 Vicodin CR 18
and cyclooxygenase, opioid receptor agonist, stem4.5 Osteoarthritis Market – Clinical Pipeline by
cell therapy, cartilage cell synthesizer.Mechanism of Action 18
- Analysis of the current and future market4.6 Osteoarthritis Pipeline – Pipeline by Clinical
competition in the global osteoarthritis market. KeyPhases of Development 19
market players covered are Novartis AG, Pfizer, Inc.,4.6.1 Osteoarthritis Therapeutics – Phase III
Johnson & Johnson and Abbott LaboratoriesClinical Pipeline 20
- Insightful review of the key industry drivers,4.6.2 Osteoarthritis Therapeutics – Phase II Clinical
restraints and challenges. Each trend is independentlyPipeline 23
researched to provide qualitative analysis of its4.6.3 Osteoarthritis Therapeutics – Phase I Clinical
implications.Pipeline 25
- Key topics covered include strategic competitor4.6.4 Osteoarthritis Therapeutics – Discovery
assessment, market characterization, unmet needsPipeline 26
and implications for future market associated with4.6.5 Osteoarthritis Therapeutics – Discontinued
osteoarthritis market.Pipeline 26
Reasons to buy:4.7 Key Takeaway 26
The report will enhance your decision making5 Osteoarthritis Market: Implications for Future
capability in a more rapid and time sensitive manner.Market Competition 27
It will allow you to:6 Osteoarthritis Market: Future Players in the
- Develop and design your in-licensing and out-licensingOsteoarthritis Market 28
strategies through review of pipeline products and6.1 Introduction 28
technologies and by identifying companies with the6.2 Novartis Pharma AG 28
most robust pipeline.6.2.1 Overview 28
- Develop business strategies by understanding the6.2.2 Osteoarthritis Disease Portfolio 29
trends shaping and driving the global osteoarthritis6.2.3 SMC021 29
market.6.3 Pfizer Inc. 29
- Drive revenues by understanding key trends,6.3.1 Overview 29
innovative products and technologies, market6.3.2 Osteoarthritis Disease Portfolio 30
segments and companies likely to impact the global6.3.3 SD6010 30
osteoarthritis market in future.6.3.4 PF-4383119 30
- Formulate effective sales and marketing strategies6.3.5 TDS-943 31
by understanding the competitive landscape and by6.4 Johnson and Johnson 31
analyzing the performance of various competitors.6.4.1 Company Overview 31
- Identify emerging players with potentially strong6.4.2 Osteoarthritis Disease Portfolio 32
product portfolio and create effective6.4.3 CG5503 32
counter-strategies to gain competitive advantage.6.5 Abbott Laboratories 32
- Organize your sales and marketing efforts by6.5.1 Company Overview 32
identifying the market categories and segments that6.5.2 Osteoarthritis Disease Portfolio 33
present maximum opportunities for consolidations,6.5.3 Vicodin CR 33
investments and strategic partnerships.7 Osteoarthritis Market: Appendix 34
- What's the next big thing in the global osteoarthritis7.1 Definitions 34
market landscape? – Identify, understand and7.2 Acronyms 34
capitalize.7.3 Research Methodology 34
Table of contents7.3.1 Coverage 35
1 Table of contents 27.3.2 Secondary Research 35
1.1 List of Tables 47.3.3 Forecasting 36
1.2 List of Figures 47.3.4 Primary Research 38
2 Osteoarthritis Market: Market Characterization 57.3.5 Expert Panel Validation 39
2.1 Overview 57.4 Contact Us 39
2.2 Osteoarthritis Therapeutics Market Size 57.5 Disclaimer 39
2.3 Osteoarthritis Market Forecast and CAGR 67.